Investigators in Brazil concluded that the severity of acute COVID-19 did not differ among patients with vitiligo, atopic dermatitis, psoriasis and other skin diseases. However, different treatments were linked to specific changes in the course of skin diseases.
- Antimalarials and hydroxychloroquine for COVID-19 were associated with clinical worsening of vitiligo. (Actually, antimalarials are oxidative drugs whose additional stress on melanocytes can influence active vitiligo.)
- Oral corticosteroids for the treatment of vitiligo lead to greater clinical impairment.
- Antihistamines for dermatological diseases were also associated with a longer symptomatic period in cases of acute COVID-19.
- Investigators believe the use of oral glucocorticoids, which were used in cases of unstable vitiligo and chronic urticaria, indicated increased exacerbation caused by viral infection.
Overall, hospitalization due to COVID-19 did not differ between respondents with and without skin diseases, though a lower rate of hospitalization was noted for respondents with vitiligo who used oral antioxidants (e.g. vitamin E, vitamin C or Polypodium leucotomos).
Further reading: Am I at higher risk of catching SARS-CoV-2 if I have vitiligo?
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...
- Isn't it just a cosmetic disorder?
Contrary to popular belief, vitiligo is not a cosmetic disorder but a systemic disease affecting the largest body organ and other vital systems, with multiple comorbidities. Fo...
- Does halo nevi affect vitiligo development?
Halo nevi — nevi with an depigmented circle around it, usually on the trunk — are about 10x more common in vitiligo patients than in the general population, especially in childr...
Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.